Case studies
Filter
-
Case study: Bringing the first anti-IL17BR antibody closer to the clinic, for atopic dermatitis and other conditions
Read more: Case study: Bringing the first anti-IL17BR antibody closer to the clinic, for atopic dermatitis and other conditions -
Case study: The first unconjugated antibody against TROP-2, humanized for KisoJi Biotechnology
Read more: Case study: The first unconjugated antibody against TROP-2, humanized for KisoJi Biotechnology -
Keytruda®: the best-selling drug that nearly wasn’t
Read more: Keytruda®: the best-selling drug that nearly wasn’t -
LifeArc collaboration helps to advance a potential new cancer drug towards the clinic
Read more: LifeArc collaboration helps to advance a potential new cancer drug towards the clinic -
Exploring new approaches to drug discovery
Read more: Exploring new approaches to drug discovery -
Developing the next generation of technology transfer specialists
Read more: Developing the next generation of technology transfer specialists -
Rising to the challenge of COVID-19
Read more: Rising to the challenge of COVID-19 -
Collaboration leads to promising new approach for Alzheimer’s disease
Read more: Collaboration leads to promising new approach for Alzheimer’s disease -
How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response
Read more: How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response -
LifeArc supports MRC spin-out to Series A funding
Read more: LifeArc supports MRC spin-out to Series A funding -
LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy
Read more: LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy -
Virtual reality technology for small molecular drug discovery
Read more: Virtual reality technology for small molecular drug discovery